LIVN Q3 2019 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q3 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$269M-1.3% YoY

Gross Profit

$179M66.8% margin

Operating Income

$26M9.6% margin

Net Income

$32M12.0% margin

EPS (Diluted)

$0.66

QoQ Revenue Growth

-3.1%

Cash Flow

Operating Cash Flow

-$77M

Free Cash Flow

-$85M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$1.0B

Stockholders' Equity

$1.5B

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$269M	$272M	-1.3%
Gross Profit	$179M	$174M	+2.9%
Operating Income	$26M	-$6M	+547.5%
Net Income	$32M	-$7M	+547.5%

Revenue Segments

Neuromodulation

$113M80%

Cardiac Surgery

$29M20%

Geographic Segments

Rest Of World

$641,000100%